Search results
Results from the WOW.Com Content Network
US firm Moderna sued American competitor Pfizer and its German partner BioNTech for alleged patent infringement in relation to their Comirnaty vaccine, arguing it was due compensation for products ...
Pfizer, BioNTech and biotech firm Promosome told a federal judge in San Diego, California that they have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a ...
A legal battle between rival developers of Covid-19 jabs over life-saving vaccine technology patents has produced a mixed ruling from a High Court judge. ... arguing it was due compensation for ...
Due to the COVID-19 pandemic, Congress and President Trump enacted the $2.2 trillion Coronavirus Aid, Relief, and Economic Security Act (CARES) on March 18, 2020. The Congressional Budget Office estimated that the budget deficit for fiscal year 2020 would increase to $3.3 trillion or 16% GDP, more than triple that of 2019 and the largest ...
In May 2020, the Open Pandemics—COVID-19 partnership was launched between Scripps Research and IBM's World Community Grid. The partnership is a distributed computing project that "will automatically run a simulated experiment in the background [of connected home PCs] that will help predict the efficacy of a particular chemical compound as a ...
On January 22, 2021, Biden released an executive order addressing the economic crisis due to COVID-19. [ 188 ] Biden voiced support for $600 extra weekly unemployment benefits, increasing Social Security checks by $200 monthly, federally funded COBRA insurance for those who have lost their jobs during the pandemic, paid sick leave, as well as ...
Biotech firm Promosome LLC sued Moderna, Pfizer and BioNTech in federal court in San Diego, California, on Tuesday, accusing their COVID-19 vaccines of infringing a patent related to messenger RNA ...
The cases are part of a wave of patent lawsuits that have been filed over technology used in the COVID-19 shots, including one filed by Moderna against Pfizer last year. Alnylam to appeal ruling ...